BRAINS Study / Platform Discovery

About B4X Therapeutics

B4X Therapeutics is an early-stage biotech applying a novel, data-centric strategy to neurodegenerative disease drug development. The company's core thesis is that the high failure rate in CNS drug development stems from a lack of deep biological data connecting patient subtypes to treatments. To address this, B4X is conducting the large-scale 'BRAINS' clinical study to build an integrated multiomic data platform, which it will use to discover and develop biomarker-guided small molecule therapeutics. This approach aims to de-risk development for partners and increase the probability of clinical success.

Therapeutic Areas